hesperetin has been researched along with kaempferol in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (19.35) | 18.2507 |
2000's | 7 (22.58) | 29.6817 |
2010's | 17 (54.84) | 24.3611 |
2020's | 1 (3.23) | 2.80 |
Authors | Studies |
---|---|
Barbhuiya, TK; Jayaprakash, V; Mohd Siddique, MU; Sinha, BN | 1 |
Chu, SC; Hsieh, YS; Lin, JY | 1 |
Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M | 1 |
Habtemariam, S | 1 |
Ash, K; Grohmann, K; Manthey, CL; Manthey, JA; Montanari, A | 1 |
Morris, ME; Yang, X; Zhang, S | 1 |
Asada, S; Imai, Y; Sugimoto, Y; Tsukahara, S | 1 |
Domina, NG; Khlebnikov, AI; Kirpotina, LN; Quinn, MT; Schepetkin, IA | 1 |
Chou, CJ; Frei, N; Grigorov, M; Lo Piparo, E; Scheib, H; Williamson, G | 1 |
Kirchmair, J; Laggner, C; Langer, T; Nashev, LG; Odermatt, A; Schuster, D; Wolber, G | 1 |
Gavande, N; Hanrahan, JR; Hibbs, DE; Kim, MS; Matin, A; Roubin, RH; Salam, NK; Yang, NX | 1 |
Amić, D; Lucić, B | 1 |
Ataide Martins, JP; Borges de Melo, E; Castro Ferreira, MM; Friozi, MC; Marinho Jorge, TC | 1 |
Itoh, T; Sakakibara, H; Shimoi, K; Takemura, H; Yamamoto, K | 1 |
Goettert, M; Koch, P; Laufer, S; Merfort, I; Schattel, V | 1 |
Cai, S; Chu, L; Gao, F; Ji, B; Jia, G; Liu, J; Liu, Y; Wang, A; Wei, Y; Wu, W; Xie, L; Zhang, D; Zhou, F | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Doddareddy, MR; Gavande, N; Groundwater, PW; Hibbs, DE; Matin, A; Nammi, S; Roubin, RH | 1 |
Atrahimovich, D; Khatib, S; Vaya, J | 1 |
Atanasov, AG; Dirsch, VM; Heiss, EH; Malainer, C; Mayerhofer, B; Schwaiger, S; Stuppner, H; Tran, TV; Vouk, C; Zimmermann, K | 1 |
Bilia, AR; Carta, F; Ceruso, M; Karioti, A; Supuran, CT | 1 |
Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM | 1 |
Alunda, JM; Baptista, C; Behrens, B; Bifeld, E; Borsari, C; Clos, J; Cordeiro-da-Silva, A; Corral, MJ; Costantino, L; Costi, MP; Dello Iacono, L; Di Pisa, F; Eick, J; Ellinger, B; Ferrari, S; Gribbon, P; Gul, S; Henrich, S; Jiménez-Antón, MD; Keminer, O; Kohler, M; Kuzikov, M; Landi, G; Luciani, R; Mangani, S; Pellati, F; Poehner, I; Pozzi, C; Reinshagen, J; Santarem, N; Tait, A; Tejera Nevado, P; Torrado, J; Trande, M; Wade, RC; Witt, G; Wolf, M | 1 |
Akram, M; Atanasov, AG; Ateba, SB; Bachmann, F; Davis, RA; Engeli, RT; Krenn, L; Leugger, S; Njamen, D; Odermatt, A; Schuster, D; Stuppner, H; Temml, V; Vuorinen, A; Waltenberger, B | 1 |
Daidone, G; Maggio, B; Plescia, F; Raffa, D; Raimondi, MV | 1 |
Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ | 1 |
Fong, J; Korobkova, EA; Maran, U; Oja, M; Rice, M; Samuels, K; Sapse, AM; Williams, AK; Wong, B | 1 |
Guengerich, FP; Kim, DH | 1 |
Choudhury, R; Chowrimootoo, G; Debnam, ES; Rice-Evans, C; Spencer, JP; Srai, SK | 1 |
Aromaa, A; Hakulinen, T; Heliövaara, M; Järvinen, R; Knekt, P; Kumpulainen, J; Reunanen, A; Rissanen, H | 1 |
Ferruzzi, MG; Jouni, ZE; Song, BJ | 1 |
3 review(s) available for hesperetin and kaempferol
Article | Year |
---|---|
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.
Topics: Animals; Antineoplastic Agents, Phytogenic; Classification; Cluster Analysis; Cytochrome P-450 CYP1B1; Enzyme Inhibitors; Humans; Molecular Mimicry; Neoplasms; Phytoestrogens | 2019 |
Recent discoveries of anticancer flavonoids.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzopyrans; Drug Discovery; Flavonoids; Humans; Neoplasms; Plants; Structure-Activity Relationship | 2017 |
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |
28 other study(ies) available for hesperetin and kaempferol
Article | Year |
---|---|
Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activity.
Topics: DNA Polymerase I; Flavonoids; Leukemia Virus, Murine; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 1992 |
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes | 1996 |
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
Topics: Animals; Apoptosis; Drug Synergism; Flavonoids; Mice; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
Topics: Citrus; Cyclic AMP; Flavonoids; Humans; In Vitro Techniques; Lipopolysaccharides; Monocytes; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 1999 |
Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Division; Chemokines, CC; Dose-Response Relationship, Drug; Drug Interactions; Flavonoids; Humans; Mitoxantrone; Neoplasm Proteins; Tumor Cells, Cultured | 2004 |
Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonoids; Genistein; Humans; K562 Cells; Neoplasm Proteins; Topotecan; Transduction, Genetic; Tritium | 2004 |
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
Topics: Animals; Antioxidants; Drug Design; Flavonoids; Humans; Phagocytes; Phenols; Polyphenols; Quantitative Structure-Activity Relationship | 2007 |
Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.
Topics: alpha-Amylases; Catalytic Domain; Digestion; Flavones; Flavonols; Humans; Hydrogen Bonding; Ligands; Models, Molecular; Protein Conformation; Saliva; Starch; Structure-Activity Relationship | 2008 |
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
Topics: 17-Hydroxysteroid Dehydrogenases; Catalysis; Cell Line; Drug Evaluation, Preclinical; Enzyme Inhibitors; Flavonoids; Humans; Models, Chemical; Small Molecule Libraries | 2008 |
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Topics: Benzopyrans; Cell Line; Humans; PPAR alpha; PPAR gamma; Structure-Activity Relationship | 2009 |
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
Topics: Flavonoids; Free Radical Scavengers; Models, Biological; Quantitative Structure-Activity Relationship; Quantum Theory; Software; Thermodynamics | 2010 |
Multivariate QSAR study on the antimutagenic activity of flavonoids against 3-NFA on Salmonella typhimurium TA98.
Topics: Algorithms; Antimutagenic Agents; Flavonoids; Fluorenes; Least-Squares Analysis; Models, Biological; Models, Molecular; Mutagens; Quantitative Structure-Activity Relationship; Salmonella typhimurium | 2010 |
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship | 2010 |
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
Topics: Animals; Flavonoids; Humans; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinase 14; Models, Molecular; Protein Kinase Inhibitors; Structure-Activity Relationship | 2010 |
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
Topics: Antioxidants; Cell Line; Fatty Liver; Flavonoids; Humans; In Vitro Techniques; Oleic Acid; Reactive Oxygen Species; Triglycerides | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists.
Topics: Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Humans; Isoflavones; Models, Molecular; Molecular Structure; Peroxisome Proliferator-Activated Receptors; Structure-Activity Relationship | 2013 |
The effects and mechanism of flavonoid-rePON1 interactions. Structure-activity relationship study.
Topics: Allosteric Site; Aryldialkylphosphatase; Copper; Flavonoids; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Molecular Docking Simulation; Oxidation-Reduction; Protein Binding; Protein Conformation; Recombinant Proteins; Spectrometry, Fluorescence; Structure-Activity Relationship; Tryptophan | 2013 |
Identification of chromomoric acid C-I as an Nrf2 activator in Chromolaena odorata.
Topics: Cell Culture Techniques; Cell Survival; Chromolaena; Fatty Acids, Unsaturated; Furans; Heme Oxygenase-1; Inflammation; Luciferases; Molecular Structure; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-E2-Related Factor 2; Plant Leaves; Vietnam | 2014 |
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
Topics: Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isoenzymes; Kinetics; Phenol; Protein Binding; Quercus; Salvia; Structure-Activity Relationship | 2015 |
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship | 2015 |
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs.
Topics: Animals; Biological Products; Cell Line; Dose-Response Relationship, Drug; Flavonols; Humans; Macrophages; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2016 |
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.
Topics: 17-Hydroxysteroid Dehydrogenases; Biological Products; Enzyme Inhibitors; Etiocholanolone; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Testosterone | 2017 |
A role of flavonoids in cytochrome c-cardiolipin interactions.
Topics: Cardiolipins; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Humans; Molecular Structure; Oxidation-Reduction; Structure-Activity Relationship | 2021 |
In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids.
Topics: Aflatoxins; Chamomile; Chromatography, High Pressure Liquid; Dihydropyridines; Felodipine; Flavanones; Flavins; Flavonoids; Gene Expression Regulation; Hesperidin; Humans; In Vitro Techniques; Kaempferols; Microsomes, Liver; Oils, Volatile; Plants, Medicinal; Quercetin; Transcriptional Activation | 1990 |
The small intestine can both absorb and glucuronidate luminal flavonoids.
Topics: Animals; Caffeic Acids; Chlorogenic Acid; Coumaric Acids; Flavonoids; Glucuronates; Hesperidin; Ileum; In Vitro Techniques; Intestinal Absorption; Jejunum; Kaempferols; Male; Perfusion; Propionates; Quercetin; Rats; Rats, Sprague-Dawley; Rutin | 1999 |
Flavonoid intake and risk of chronic diseases.
Topics: Adult; Arthritis, Rheumatoid; Asthma; Cataract; Cerebrovascular Disorders; Chronic Disease; Diabetes Mellitus, Type 2; Diet; Female; Flavanones; Flavonoids; Hesperidin; Humans; Kaempferols; Lung Neoplasms; Male; Middle Aged; Mortality; Myocardial Ischemia; Neoplasms; Prostatic Neoplasms; Quercetin; Risk; Risk Factors; Surveys and Questionnaires | 2002 |
Assessment of phytochemical content in human milk during different stages of lactation.
Topics: Adult; Carotenoids; Catechin; Cryptoxanthins; Female; Flavanones; Flavonoids; Hesperidin; Humans; Kaempferols; Lactation; Lutein; Lycopene; Milk, Human; Postpartum Period; Pregnancy; Quercetin; Time Factors; Xanthophylls; Zeaxanthins | 2013 |